First-in-class siRNA therapeutic targeting protein S to prevent bleeding and joint/bone damage

Forschungsstelle

INNOSUISSE

Projektnummer

134.426 IP-LS

Projekttitel

First-in-class siRNA therapeutic targeting protein S to prevent bleeding and joint/bone damage

Projekttitel Englisch

First-in-class siRNA therapeutic targeting protein S to prevent bleeding and joint/bone damage

Texte zu diesem Projekt

	Deutsch	Französisch	Italienisch	Englisch
Schlüsselwörter	-	-	-
Abstract	-	-	-

Kategorie	Text
Schlüsselwörter (Englisch)	Life sciences, Biotechnology and processing
Abstract (Englisch)	BnF-001 is a first-in-class siRNA providing a controlled targeting of protein S as a universal treatment for hemophilia and allied bleeding disorders by preventing bleeding and preserving joint and bone health. Preclinical studies address candidate selection, development, safety and efficacy.